Dr. Murthy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Road S
Jacksonville, FL 32224
Summary
- Dr. Hemant Murthy is a hematologist in Jacksonville, FL and is affiliated with Mayo Clinic Hospital in Florida and Associate Professor of medicine at the Mayo Clinic. He specializes in hematologic oncology and is experienced in immunotherapy, hematopoietic stem cell transplantation, car-T and immunotherapy, and leukemia and myeloid disorders
Education & Training
- H. Lee Moffitt Cancer Center and Research InstituteBone marrow transplant , 2015 - 2016
- Vidant Medical Center/East Carolina UniversityFellowship, Hematology and Medical Oncology, 2012 - 2015
- Virginia Commonwealth University Health SystemFellowship, Hospice and Palliative Medicine, 2011 - 2012
- SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2008 - 2011
- St. George's University School of MedicineClass of 2008
- State University of New York at BinghamtonBS, Chemistry, 1998 - 2002
Certifications & Licensure
- FL State Medical License 2015 - 2025
- NC State Medical License 2012 - 2016
- VA State Medical License 2011 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Resident/ Fellow Scholarship VCU Deparment of Medicine, 2012
- AAHPM HPNA Annual Assembly Palliative Medicine Access Fund Scholarship 2012
Clinical Trials
- Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101) Start of enrollment: 2017 Aug 18
Publications & Presentations
PubMed
- Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.Naseema Gangat, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Fnu Aperna
American Journal of Hematology. 2024-12-13 - Rethinking Measures and Mortality Attribution in Health Care: The ENT Example.Samip Patel, Lorenzo Olivero, Jorge Sinclair De Frias, Stephanie S Anderson, Ben D Pollock
Otolaryngology--Head and Neck Surgery. 2024-12-01 - T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia.Talha Badar, Keith Knutson, James M Foran, Naseema Gangat, Kevin D Pavelko
Blood Advances. 2024-11-21
Journal Articles
- Pharmacokinetic and Clinical Outcomes When Ideal Body Weight Is Used to Dose Busulfan in Obese Hematopoietic Stem Cell Transplant RecipientsJack W Hsu, Hemant S Murthy, Nature
Abstracts/Posters
- Diet Quality of Long-Term Allogeneic and Autologous Stem Cell Transplant (HCT) SurvivorsHemant S. Murthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Efficacy of Allogeneic Hematopoietic Cell Transplantation (HCT) in Sickle Cell Disease: Results of a Systematic Review/Meta-AnalysisHemant S. Murthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)Hemant S. Murthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- The Perils Of Palliative Care- Recognizing When Palliative Interventions Are The Cause Of Symptom Burden.Annual Assembly of the American Academy of Hospice and Palliative Medicine and Hospice
- Lymphedema- A Growing Problem.Department of Hematology, Oncology and Palliative Medicine, Virginia Commonwealth University
Authored Content
- Recent Research Brings Improved Outcomes in Allogeneic Hematopoietic Cell TransplantationFebruary 2021
- State of the science: High-priority transplant trials for nonmalignant diseaseApril 2015
Press Mentions
- Looking Back on 2020: A Successful Year of Research at Mayo Clinic in FloridaJanuary 5th, 2021
- FDA Says CAR-T Therapy for Cancer Treatment May Increase Cancer RiskJanuary 24th, 2024
- FDA Says Cancer Treatment CAR-T Therapy May Increase Risk of CancerJanuary 24th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Fellow
- American Association of Hospice and Palliative MedicineMember
- American Society of NeurooncologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: